Stay informed

Meiogenix is a featured Scale-up at World Agri-Tech

Meiogenix, Inc, a biotechnology company pioneering targeted recombination to unlock the full genetic potential of crops, is proud to announce the publication of its latest peer-reviewed research in Fr

Meiogenix is a featured Startup at World Agri-Tech San Francisco.

Meiogenix, Inc, is pleased to announce the appointment of Mary Beth Miranda, Ph.D. as its new Chief Business Development Officer.

Meiogenix is proud to announce Dr. Gaganpreet Sidhu as its new Chief Technology Officer.

Company Brings On Industry Leader to Address Increasing Demand for Solutions that Unlock Natural Genetic Diversity of Crops to Deliver Advanced Variety Development

Meiogenix is pleased to announce that Dr. Neal Gutterson has joined the Meiogenix Board of Directors.

Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, has joined Cornell’s McGovern Center business.

Co-investors include Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments.

A Cornell professor is collaborating with European partners to engineer maize – the largest staple crop in the world – with desirable traits, from resistance to disease to climate resilience.